Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 1Phase 2 1Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Osteoporosis 2Prostatic Neoplasms 1Hypogonadism 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Alendronate × Clear all
NCT00177619 2014-02-11

Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)

University of Pittsburgh

Phase 3 Completed
120 enrolled
Genitourinary

Hypogonadism, Prostatic Neoplasms

NCT00236002 2009-08-12

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

Canadian Urology Research Consortium

Phase 3 Terminated
182 enrolled

Osteoporosis

NCT00391404 2008-05-23

Fosamax for Childhood Cancer Survivors

Chinese University of Hong Kong

Phase 3 Unknown
100 enrolled

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡